BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34413853)

  • 1. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity.
    Lopes AP; Hillen MR; Hinrichs AC; Blokland SL; Bekker CP; Pandit A; Kruize AA; Radstake TR; van Roon JA
    Ann Rheum Dis; 2023 Mar; 82(3):374-383. PubMed ID: 36171070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
    Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed genes in primary Sjögren's syndrome.
    Zhang L; Xu P; Wang X; Zhang Z; Zhao W; Li Z; Yang G; Liu P
    J Cell Biochem; 2019 Oct; 120(10):17368-17377. PubMed ID: 31125139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
    Maria NI; Brkic Z; Waris M; van Helden-Meeuwsen CG; Heezen K; van de Merwe JP; van Daele PL; Dalm VA; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren's Syndrome.
    Oyelakin A; Horeth E; Song EC; Min S; Che M; Marzullo B; Lessard CJ; Rasmussen A; Radfar L; Scofield RH; Lewis DM; Stone DU; Grundahl K; De Rossi SS; Kurago Z; Farris AD; Sivils KL; Sinha S; Kramer JM; Romano RA
    Front Immunol; 2020; 11():606268. PubMed ID: 33488608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.
    Lopes AP; Hillen MR; Chouri E; Blokland SLM; Bekker CPJ; Kruize AA; Rossato M; van Roon JAG; Radstake TRDJ
    PLoS One; 2018; 13(2):e0193157. PubMed ID: 29447268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
    Imgenberg-Kreuz J; Sandling JK; Almlöf JC; Nordlund J; Signér L; Norheim KB; Omdal R; Rönnblom L; Eloranta ML; Syvänen AC; Nordmark G
    Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.
    Hong J; Cheng H; Wang P; Wu Y; Lu S; Zhou Y; Wang XB; Zhu X
    Arthritis Res Ther; 2024 Jan; 26(1):26. PubMed ID: 38229121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.
    Lisi S; Sisto M; Ribatti D; D'Amore M; De Lucro R; Frassanito MA; Lorusso L; Vacca A; Lofrumento DD
    J Mol Med (Berl); 2014 May; 92(5):523-37. PubMed ID: 24557415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique Sjögren's syndrome patient subsets defined by molecular features.
    James JA; Guthridge JM; Chen H; Lu R; Bourn RL; Bean K; Munroe ME; Smith M; Chakravarty E; Baer AN; Noaiseh G; Parke A; Boyle K; Keyes-Elstein L; Coca A; Utset T; Genovese MC; Pascual V; Utz PJ; Holers VM; Deane KD; Sivils KL; Aberle T; Wallace DJ; McNamara J; Franchimont N; St Clair EW
    Rheumatology (Oxford); 2020 Apr; 59(4):860-868. PubMed ID: 31497844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key mitochondria-related genes and their relevance to the immune system linking Parkinson's disease and primary Sjögren's syndrome through integrated bioinformatics analyses.
    Zong Y; Yang Y; Zhao J; Li L; Luo D; Hu J; Gao Y; Xie X; Shen L; Chen S; Ning L; Jiang L
    Comput Biol Med; 2024 Jun; 175():108511. PubMed ID: 38677173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
    Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
    Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
    Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
    Front Immunol; 2021; 12():697157. PubMed ID: 34367157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of epithelium-associated FcRL4
    Verstappen GM; Ice JA; Bootsma H; Pringle S; Haacke EA; de Lange K; van der Vries GB; Hickey P; Vissink A; Spijkervet FKL; Lessard CJ; Kroese FGM
    J Autoimmun; 2020 May; 109():102439. PubMed ID: 32201227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome.
    Shi H; Cao N; Pu Y; Xie L; Zheng L; Yu C
    Arthritis Res Ther; 2016 May; 18(1):109. PubMed ID: 27188286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.